Insights
Featured Carousel
- ESG in Focus: An Overview of Recent Litigation and Regulatory Developments
- Hitting Reset or Flipping the Table? SEC Staff Significantly Increases the Unpredictability of the Shareholder Proposal No-Action Process
- Public Comments on US Merger Guidelines May Be Harbinger of Stronger Enforcement
- EU and UK Revamp Antitrust Rules on Distribution Arrangements
- The Informed Board
Topics Panel Section
Video: A Closer Look at the New SEC Crypto Assets and Cyber Unit
Longtime colleagues at the SEC's Division of Enforcement, partners Anita Bandy and Dan Michael provide an insider's look at what the SEC's new Crypto Assets and Cyber Unit means for companies. The unit is part of SEC Chair Gary Gensler's larger effort to regulate the crypto markets and protect investors.
A Closer Look at the New SEC Crypto Assets and Cyber Unit (Video)
Podcast: How Antitrust Regulators and the SEC Are Advancing the Wider Biden Agenda
In this inaugural episode of the Informed Board podcast, Skadden partners Maria Raptis and Raquel Fox join our host Ann Beth Stebbins to discuss changing approaches to antitrust and securities regulation in Washington. They talk about new priorities in antitrust enforcement, new disclosure initiatives by the Securities and Exchange Commission, and the obstacles that could hinder regulatory rulemaking.
How Antitrust Regulators and the SEC Are Advancing the Wider Biden Agenda
Longtime colleagues at the SEC's Division of Enforcement, partners Anita Bandy and Dan Michael provide an insider's look at what the SEC's new Crypto Assets and Cyber Unit means for companies. The unit is part of SEC Chair Gary Gensler's larger effort to regulate the crypto markets and protect investors.
A Closer Look at the New SEC Crypto Assets and Cyber Unit (Video)
In this inaugural episode of the Informed Board podcast, Skadden partners Maria Raptis and Raquel Fox join our host Ann Beth Stebbins to discuss changing approaches to antitrust and securities regulation in Washington. They talk about new priorities in antitrust enforcement, new disclosure initiatives by the Securities and Exchange Commission, and the obstacles that could hinder regulatory rulemaking.
How Antitrust Regulators and the SEC Are Advancing the Wider Biden Agenda
Our second annual report on Hong Kong-listed biotech companies demonstrates the continued health of the sector. The report provides a comprehensive overview of the market in its current state, examining key data points for biotech companies undertaking IPOs on the HKEX in calendar year 2021 and analyzing the corporate governance practices of all 48 biotech companies listed on HKEX as of December 31, 2021.
Report on Hong Kong-Listed Biotech Companies
Response to the Russian invasion of Ukraine has been swift and coordinated, with the U.S., U.K. and EU, among other allied nations, imposing a series of sanctions and export controls on key elements of the Russian economy. We are watching the space closely and will update this page with new client alerts as developments unfold.
Report on Hong Kong-Listed Biotech Companies
Our second annual report on Hong Kong-listed biotech companies demonstrates the continued health of the sector. The report provides a comprehensive overview of the market in its current state, examining key data points for biotech companies undertaking IPOs on the HKEX in calendar year 2021 and analyzing the corporate governance practices of all 48 biotech companies listed on HKEX as of December 31, 2021.
Report on Hong Kong-Listed Biotech Companies
Update on Russia Sanctions
Response to the Russian invasion of Ukraine has been swift and coordinated, with the U.S., U.K. and EU, among other allied nations, imposing a series of sanctions and export controls on key elements of the Russian economy. We are watching the space closely and will update this page with new client alerts as developments unfold.
Latest From Skadden
-
Regulatory Actions and Legislative Proposals Signal Growing Consensus on Parameters for StablecoinsJune 29, 2022
-
Skadden Discusses Delaware Court Rulings on Advance Notice Bylaws and Incumbent Director ConductJune 29, 2022
-
Report on Hong Kong-Listed Biotech CompaniesJune 28, 2022